Group 1 - Achilles Therapeutics PLC Sponsored ADR (ACHL) is currently ranked 5 in the Zacks Sector Rank among 1016 companies in the Medical group, indicating strong performance relative to peers [1] - The Zacks Rank for ACHL is 2 (Buy), suggesting a favorable outlook based on earnings estimate revisions and improving earnings outlooks [1] - Year-to-date, ACHL has increased by approximately 17%, outperforming the Medical sector's average return of 10.8% [2] Group 2 - ACHL belongs to the Medical - Biomedical and Genetics industry, which has 495 stocks and is currently ranked 79 in the Zacks Industry Rank, indicating better performance compared to the industry average gain of 2.2% [3] - In contrast, Butterfly Network, Inc. (BFLY), which is in the Medical Info Systems industry ranked 67, has seen its industry decline by 7.7% since the beginning of the year [3] - Both ACHL and BFLY are highlighted as stocks to watch for maintaining solid performance in the Medical sector [3]
Is Achilles Therapeutics (ACHL) Stock Outpacing Its Medical Peers This Year?